CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $873,000 | +2.9% | 241,699 | +0.8% | 0.23% | -27.9% |
| Q4 2016 | $848,000 | -83.1% | 239,662 | -80.7% | 0.32% | -79.0% |
| Q3 2016 | $5,022,000 | -9.5% | 1,243,164 | -1.7% | 1.52% | -19.9% |
| Q2 2016 | $5,550,000 | +48.4% | 1,264,227 | +27.8% | 1.90% | +39.6% |
| Q1 2016 | $3,740,000 | -62.6% | 989,376 | +55.3% | 1.36% | -58.8% |
| Q4 2015 | $9,992,000 | +31.9% | 637,238 | -11.3% | 3.30% | +40.2% |
| Q3 2015 | $7,575,000 | -36.3% | 718,729 | +52.4% | 2.35% | -32.0% |
| Q2 2015 | $11,893,000 | – | 471,554 | – | 3.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
| TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
| Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
| RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
| Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
| Bellevue Group AG | 160,000 | $566,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
| PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
| Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |